chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Complained of SOB, "crampy, sharp" non-radiating substernal chest pain (fluctuating in severity, the most severe becoming 8/10), fatigue, palpitations, HA, and sore throat which started on 6/14/21. Pt received her second Pfizer COVID19 immunization on 6/11/21. The first symptom to start was sore throat on 6/14/21, however Pt underwent negative strep and mono testing that same day. Pt's other sx began shortly thereafter, the most distressing symptom being the chest pain and SOB.   ED Course: --febrile (39.3), tachycardic, and tachypneic which met SIRS criteria --received 20cc/kg fluid bolus --first doses of vancomycin, Zosyn started; Pt reported flushing and pruritis with vancomycin administration  Currently hospitalized
Arm pain; fatigue; diarrhea; This is a spontaneous report from a contactable consumer (patient, self-reported). A 53-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9766 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 25Feb2021 at 01:15 PM, as a single dose for COVID-19 immunization at hospital. The patient did not receive any other vaccine in four weeks. The patient's medical history included HIV, rheumatoid arthritis, asthma, and adrenal insufficiency. The patient did not have any known allergies. Concomitant medications were not reported. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient reported that on 26Feb2021, he experienced arm pain, fatigue, and diarrhea. The patient did not receive any treatment for the events. Outcome of the events was recovered on an unknown date.   No follow-up attempts are possible. No further information is expected.
Within 24 hours of vaccine, patient began to experience recurrence of nerve pain in the same site he had experienced shingles in the past. Nerve pain still present 8 days later although beginning to subside.
4PM felt flushed & lightheaded; BP 160/112; pulse 96; resp 20; 404PM  BP 140/110, P104, R20-offered ammonia; 409PM BP 140/100, P100, R20; 414PM felt hypersensitive to touch BP 120/90, P88, R20; 418PM felt scalp/face tingling BP130/100;
Complained of a metalic taste minute after injection. Then felt jaw tightening and then felt tingling and dizzy feeling, nauseous, jittery. Bp 140/86 Hr 95. 12:40pm had Benadryl 50mg. 1:35pm left for ER with her husband.
Information has been received from a registered nurse referring to unspecified patients of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. The patients were administered improperly stored doses of GARDASIL 9 (Lot L020015, expiration date 16-AUG-2017, dose and route were unknown) on the following dates: 19-APR-2016 (1 dose), 16-MAY-2016 (1 dose), 31-MAY-2016 (1 dose), and 01-JUN-2016 (1 dose). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sore arm; fast heartbeat lasted for 30 mins; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and HEART RATE INCREASED (fast heartbeat lasted for 30 mins) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002821A) for COVID-19 vaccination.     The patient's past medical history included Bypass surgery. Concurrent medical conditions included Penicillin allergy.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEART RATE INCREASED (fast heartbeat lasted for 30 mins). At the time of the report, PAIN IN EXTREMITY (Sore arm) and HEART RATE INCREASED (fast heartbeat lasted for 30 mins) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Heart rate: unknown High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Patient received tetanus booster in ER after finger trauma. Several days later presented with warmth, tenderness and erythema rash at injection sites. Last tetanus 6 years prior. Follow up 03/02/05: Patient did not receive vaccination from us, date of adverse event, onset date/time and manufacturere unknown.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 05-NOV-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 0.5 mL (Vls 10 SDV) (Lot # K007822, expiration date 15-AUG-2016) single dose, route and anatomical location were not provided. There was no concomitant medication provided. No adverse effects were reported. On an unknown date, the PNEUMOVAX had a temperature excursion for 40 and 72 hours, the lowest recorded temperature was 28F (-2.222Celsius) and the highest was 47F (8.333 Celsius). The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". There was no product quality complaint involved. This is one of several cases received from the same reporter. Additional information has been requested.
I got the vaccine 09/2022 I contracted Covid 02/17/2023.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In September 2016, a pharmacist at a pharmacy administered the ZOSTAVAX vaccine to the patient (lot number, dosage and route of administration not provided). In January 2017, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity, and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Information has been received on 02/21/2002 from a licensed practical nurse with a history of splenectomy (30 years ago) who in December 2001 was vaccinated with one dose of hep A vaccine from a recalled lot. The nurse reported that she was "not being adequately protected because of the vaccine," and was going to have serology testing to determine if she acquired hepatitis A. It was noted that the nurse was at "high risk," since she had a splenectomy. Additional info has been requested.
Tinnitus, hissing and ringing for 3.5 weeks at this point.  Started suddenly approximately 3.5 weeks following my first vaccine shot and a couple for days prior to my second vaccine.
Pt called RN on 11/1/02 to report she experienced a rash on her legs approx. 3 hrs after receiving flu shot on 10/31/02. Denies other s/s. She took Benadryl and rash subsided. She reports she was wearing new slacks. Client reported that rash developed one hour post wearing slacks and looked like "measles." She states she felt as if her legs were on fire.
administered with vaccine stored in the refrigerator for more than 30 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with vaccine stored in the refrigerator for more than 30 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with vaccine stored in the refrigerator for more than 30 days). On 30-Jun-2021, EXPIRED PRODUCT ADMINISTERED (administered with vaccine stored in the refrigerator for more than 30 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported.  Treatment information was not provided.
Expected the slight fever, 100.2 but also noticed a pulse rate of over 100?   100-110  Is that normal?   Comes down to ~95
On 10/22, corner of right eye was swollen.  !0/24, right eye extremely swollen and fluid pocket below eye.  Left side of lip and left cheek swollen.  These symptoms disappeared towards evening.  On 10/25, bottom of feet and palms were red and itching.  Some spots appeared on torso, legs, and arms.  On 10/26, front and back of upper torso and upper and lower limbs had rash, which appeared as blisters after getting up in the morning, then dissipated throughout the day.  Took 25 mg of Benadryl and this controlled the symptoms.  They then gradually become worse.  Went to clinic on 11/8, with severe rash on body, except for face and head, and pubic area.  Doctor stated it appeared as shingles, but rash covered the whole body, not just one side or in a line.  CBC blood test and metabolic panel results were within normal limits.  Blood pressure elevated to 170/100.  MD unable to make diagnosis or have any suggestions to cause of events.  On 11/9 in evening, lungs began to fill with fluid.  Benadryl taken again.  11/10, went to see an allergist.  He gave cortisone injection and one week of prednisone.  After two days of prednisone, rash disappeared.  Blood pressure now back to normal.
This spontaneous report as received from a pharmacist refers to a 64 year old female patient with no reported medical history. On 09-SEP-2013 the patient was vaccinated with ZOSTAVAX lot # J002777 dose 1, 0.65 ml, subcutaneous. No other suspect therapy or concomitant medication was reported. On 09-SEP-2013, 1 day after onset of therapy the patient experienced itching and redness covering approximately 2 inches at the injection site along with a broken blood vessel in left eye causing redness and pain. The pharmacist stated that "no rash has occurred". The patient used a cold compress to treat the redness and itching at the injection site. The patient went to an unspecified eye specialist who prescribed LOTEMAX (manufacturer unknown). The patient is currently having the prescription filled at the pharmacy and has not begun using LOTEMAX (manufacturer unknown) yet. The patient reported that the unspecified eye specialist stated that she is the second person that he's seen who developed a broken blood vessel in the eye after receiving ZOSTAVAX. The outcome of itching and redness covering approximately 2 inches at the injection site and broken blood vessel in left eye causing redness and pain was reported as not recovered/not resolved. The reporters relatedness of itching and redness covering approximately 2 inches at the injection site and broken blood vessel in left eye causing redness and pain to ZOSTAVAX is unknown. Same reporter link: 1310USA000897. Additional information has been requested.
w/in 2 days facial rash, chills, sweats;local swelling involving entire upper arm around inj site, erythema;
Subject woke up at 3 am June 13, 2006 with headache, left arm pain at injection site and left shoulder pain. Took 400 mg Ibuprofen; could not sleep due to pain. Took 400 mg Ibuprofen again at 7am. As the day went on, headache worsened. Eyes sensitive to light; noise made headache worse; lightheaded. Noted muscle ache in neck area. The next morning the subject still had a mild, right-side headache. Took 400 mg Ibuprofen and the headache subsided. All symptoms resolved on June 14, 2006.
Shot around 3:30. Arm sore around injection around 7:00. Went to bed early. Just felt tired. Woke up around 2 am and had cold chills and nausea. General feeling of being run down. Slept most of the day. Felt slightly better next morning, still a little nausea.
pt's mother called pt complained of soreness at the site and feeling cold. The next day she c/o her heart racing and feeling some discomfort in her chest.
I have had back pain ever since the day I got the vaccine.; This is a spontaneous report from a contactable other HCP (patient).   A 38-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm right on 13Feb2021 11:30 (Lot Number: EL9262) as single dose for covid-19 immunisation. The patient received the first dose lot # EL3249 on 21Jan2021 12:30 right arm. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. No known allergies.  The patient medical history was not reported. No other medications in two weeks. The patient experienced 'back pain ever since the day i got the vaccine' on 13Feb2021 13:30. Unknown if treatment received. The outcome was not recovered.
This spontaneous prospective pregnancy report as received from a physician refers to a female patient of currently 22 years old. The patient has a history of 4 previous pregnancies and 2 live births on 39 and 40 weeks from last menstrual period (LMP). No birth defects or no infant complications in previous pregnancies were present. On 16-JAN-2014 the patient was vaccinated with the third dose GARDASIL (lot # H020901, expiration date 05-JUL-2015). The patient became pregnant with LMP of 06-DEC-2013 and estimated date of delivery (EDD) of 12-SEP-2014. Initial exposure to GARDASIL was at 6 week(s). Additional information has been requested.
Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: 20 minutes after the vaccine patient passed out for a few seconds, felt cotton mouth and flushed skin. Had water, rested for 30 minutes near the pharmacy and left walking by herself
One day after MCV administration, muscular weakness developped starting in legs and progressing to arms. No resp symptoms. Clinically normal neuro exam, normal reflexes and sensation. Missed 2 days of school due to weakness and then went to emergency department on 5/31 because he was too weak to get out of bed. Weakness resolved, no further symptoms as of 2 weeks later, reviewed by PCP, no further testing or diagnostics.
The vial of Pfizer vaccine produced only three 0.3mL and one 0.2mL syringe. The doses were not all drawn up at once. 2 were drawn up and 2.5 hours later our RN went to draw up another dose for a patient an questioned the amount in the vial, knowing only 2 had already been drawn up. She drew up the remainder in the vial and got one 0.3mL and 0.2ml. The decision was made to discard those two and reconstitute a new vial.  The MA that reconstituted the vial was adamant that she did the process correctly using a 3mL syringe and 21g needle to insert the diluent and 1mL syringe with needle already attached to draw out the vaccines.  The recommendation was made to all staff to draw up all vaccines immediately after reconstituting moving forward.  Patient was not notified as we don't know that they received an incorrect dosage.
patient received 2nd dose of pfizer COVID vaccine in left arm on 2/27/2021.  she reports on  3/2/2021 that she developed a rash on her abdomen.
Six days post vax, the pt experienced a fever, headache, severe joint pains and flu like symptoms.
probable sz the day p/vax; pt also had assoc fever & bronchiolitis infect;
Information has been received from a physician concerning a 79 year old retired female patient who was vaccinated into the upper arm with a first dose of Pneumovax 23 (lot#651404/0352F).  Subsequently, the patient experienced a redness and swelling site reaction.  The patient was treated with BENADRYL.  Unspecified medical attention was sought.  Subsequently, the patient recovered.  No product quality complaint was involved.  Additional information is not expected.
on  3/9 person reports for 2nd vaccine and reports that they had severe itching after the last vaccine. went to ER on 2/14 and had evaluation
Chest felt tight, little bit of wheezing, took some Benadryl.  Started to feel better, but by around 7 pm she was gasping for breathe, wheezing, h/a, chest tightness.  MMC treated her with Prednisone and Zantac.  Felt 90% better after that.
Parents used the wrong birthdate on the immunization consent form to get their child vaccinated before 12yo.  Parents used the same (wrong) birthdate on the second shot (8/9/21) as well. Called mother on 2/15/22 and she stated patient had no side effects.
Superficial thrombophlebitis left dorsal foot (soreness, redness over vein) occurred approx May-early June 2021, recurred Nov-December 2021.  Severe left foot pain, swelling occurred Jan15, 2022. Ultrasound showed lateral plantar vein thrombosis L foot, no other DVT.  Treatment w ASA. Improved with no pain approx 6 weeks later.
arm soreness; Local redness "2-3 inches below injection site and about 6 inches wide"; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) and INJECTION SITE ERYTHEMA (Local redness "2-3 inches below injection site and about 6 inches wide") in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm soreness) and INJECTION SITE ERYTHEMA (Local redness "2-3 inches below injection site and about 6 inches wide"). At the time of the report, PAIN IN EXTREMITY (arm soreness) and INJECTION SITE ERYTHEMA (Local redness "2-3 inches below injection site and about 6 inches wide") outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
pt recv vax 16AUG95 & on 25OCT95 pt devel a mild case of mild chickenpox w/more pox than last time;pt had scattered papular lesions mostly on trunk & arm;
dizziness, blurry vision with bright-light flashes (per pt "unable to see clear"),  hearing impaired at left ear
started with headache on 8/22/19, continued into 8/23/19 with aches and tiredness (slept 12.5 hours). 8/24/19 2am woke up with stabbing pain in both knees-took 2 MM EX arthritis tylenol, then had fever blister on right side of upper lip and nose. continued to take tylenol every 8 hours through sat.  Sunday 8/25/19 felt better, took BP and was running high (160-170), went to dr mon 8/26/19 for 6 month check up, started new med (amlodipine 2.5mg  Fri 8/30/19) Thur pm 8/29/19 woke up with both ears plugged and could not hear well.   Fri 8/30/19 called dr, they called in rx for valtrex 1gm to take bid for 1 day.
ringing in ears as indicated above, started two days after second shot  It has NOT ended!!!!
Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: BLISTER WITH FLUID-Severe, Additional Details: PT COMPLAINED ABOUT BLISTER,PAIN, REDNESS AND ITS NOT GONE.
dizziness, nauseas, dry mouth, Shortness of breath, see light spots Solu-Medrol 125mg IVP slowly Benadryl 50mg IVPB refer to ED
possible administration of invalid dose to patients; Freezer temperature never reached an acceptable range and was always warm by at least 2 degree C; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Freezer temperature never reached an acceptable range and was always warm by at least 2 degree C) and POOR QUALITY PRODUCT ADMINISTERED (possible administration of invalid dose to patients) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In April 2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Freezer temperature never reached an acceptable range and was always warm by at least 2 degree C). On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (possible administration of invalid dose to patients). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Freezer temperature never reached an acceptable range and was always warm by at least 2 degree C) and POOR QUALITY PRODUCT ADMINISTERED (possible administration of invalid dose to patients) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  There were 4 days temperature data for the freezer storage unit between 1-APR-2022 and 4-APR-2022, however it never reached an acceptable range and was always warm by at least 2 degrees C.   Treatment information was not reported.
soreness in my arm from the [Pfizer COVID-19] shots; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (176890). The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunization, reaction(s): "soreness in my arm from the [Pfizer COVID-19] shots". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "soreness in my arm from the [Pfizer COVID-19] shots".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200114074 Same patient/vaccine/event, different vaccine dose;
In 5 minutes after injection my entire arm felt a tight squeeze and radiating coolness/warmth (like I took Bengay) then fingers tingled along with tightness in left oblique and chest and back of my neck tingled.  Also onset headache within 1 hour after.  Next day (today) I feel 100%.